Loading…

Mitochondrial translation factors reflect coordination between organelles and cytoplasmic translation via mTOR signaling: Implication in disease

Mitochondria are semi-autonomous organelle possessing their own translation machinery to biosynthesize mitochondrial DNA (mtDNA)-encoded polypeptides, which are the core subunits of oxidative phosphorylation (OXPHOS) complexes. Mitochondrial translation elongation factor 4 (mtEF4) is a key quality c...

Full description

Saved in:
Bibliographic Details
Published in:Free radical biology & medicine 2016-11, Vol.100, p.231-237
Main Authors: Cao, Xintao, Qin, Yan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mitochondria are semi-autonomous organelle possessing their own translation machinery to biosynthesize mitochondrial DNA (mtDNA)-encoded polypeptides, which are the core subunits of oxidative phosphorylation (OXPHOS) complexes. Mitochondrial translation elongation factor 4 (mtEF4) is a key quality control factor in mitochondrial translation (mt-translation) that regulates mitochondrial tRNA translocation and modulates cellular responses by influencing cytoplasmic translation (ct-translation). In addition to mtEF4, mt-translational activators, mitochondrial microRNAs (mitomiRs), and MITRAC have been reported recently as crucial mt-translation regulators. Here, we focus on the novel ways how these factors regulate mt-translation, discuss the main cellular response of mammalian target of rapamycin (mTOR) signalling upon mt-translation defects, and summarize the related human diseases. [Display omitted] •mtEF4 is an elongation factor regulating tRNA translocation in mitoribosome.•Activators, mitomiRs and MITRAC are direct regulators of mt-translation machinery.•Mitochondrial and cytoplasmic translations are coordinated via mTOR signaling.•Mitochondrial translation (regulatory) factors defects induce various human diseases.
ISSN:0891-5849
1873-4596
DOI:10.1016/j.freeradbiomed.2016.04.010